Cargando…
Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for the prevention and control of peritoneal metastasis in patients with gastrointestinal malignancies: a systematic review of randomized controlled trials
Peritoneal metastasis is associated with poor prognosis, with studies in the literature reporting the survival of peritoneal metastasis without treatment to be three to six months. Hyperthermic intraperitoneal chemotherapy (HIPEC) has shown positive outcomes by improving the prognosis in patients wi...
Autores principales: | Dominic, Jerry Lorren, Kannan, Amudhan, Tara, Anjli, Hakim Mohammed, Abdul Rub, Win, Myat, Khorochkov, Arseni, Sultan, Waleed, Ahmed, Asma, Kantamaneni, Ketan, Syzmanski, Michael W., Singh, Rajbir, Marquez, Raul A., Asarian, Armand, Thirunavukarasu, Pragatheeshwar, Keckeisen, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495114/ https://www.ncbi.nlm.nih.gov/pubmed/34650387 http://dx.doi.org/10.17179/excli2021-4108 |
Ejemplares similares
-
A Systematic Review of Fibrin Glue as an Ideal Treatment for the Pilonidal Disease
por: Win, Myat, et al.
Publicado: (2021) -
Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites
por: Jiao, Jie, et al.
Publicado: (2020) -
Is Single-Dose Antimicrobial Prophylaxis Sufficient to Control Infections in Gastrointestinal Oncological Surgeries?
por: Kannan, Amudhan, et al.
Publicado: (2021) -
Past, Present, and Future of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer
por: Mishra, Mona, et al.
Publicado: (2021) -
Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review
por: Brenkman, H. J. F., et al.
Publicado: (2019)